APGE vs VRTX: Which Stock is Better?

Side-by-side comparison of Apogee Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

APGE

Apogee Therapeutics Inc

$74.68

VRTX

Vertex Pharmaceuticals Inc

$492.38

Key Metrics Comparison

MetricAPGEVRTXWinner
Market Cap$5.19B$126.79BVRTX
P/E RatioN/A32.58VRTX
EPS (TTM)$N/A$15.32VRTX
Revenue Growth0.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze APGE

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APGE or VRTX a better investment?

Comparing APGE and VRTX: Apogee Therapeutics Inc has a market cap of $5.19B while Vertex Pharmaceuticals Inc has $126.79B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APGE and VRTX?

APGE (Apogee Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APGE or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: APGE or VRTX?

VRTX has higher revenue growth at 0.1% vs 0.0% for APGE.

Which company is more profitable: APGE or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for APGE.

Which is the larger company: APGE or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.79B compared to $5.19B for APGE.

Should I buy APGE or VRTX in 2026?

Both APGE and VRTX have investment merit. APGE trades at $74.68 while VRTX trades at $492.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APGE and VRTX stock?

Key differences: Market Cap ($5.19B vs $126.79B), P/E Ratio (N/A vs 32.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons